Analyst consensus rating
CONMED Analyst Rating: none
CNMD is rated none by 6 analysts with a $45.50 target. As of 2026-08-27.
Direct answer
CONMED's consensus rating is none.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $45.50.
Forecast evidence checked August 27, 2026.
Get free CONMED email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $50.48
- Average price target
- $45.50
- High price target
- $49.00
- Low price target
- $43.00
- Low target gap
- -14.8%
- Target upside
- -9.9%
- High target gap
- -2.9%
- Target range width
- 11.9%
- Consensus rating
- none
- Analysts
- 6
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for CONMED?
CONMED has a verified none consensus. The same dataset has an average price target of $45.50.
How far are CONMED's low and high targets from the recorded price?
The low target implies -14.8%, while the high target implies -2.9%.
How many analysts are included in CONMED's consensus?
The verified consensus includes 6 analysts.
How is CONMED's target upside or downside calculated?
The average target of $45.50 is divided by the recorded price of $50.48, then one is subtracted to produce -9.9%. This does not guarantee a future return.
When was CONMED's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.